UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple-Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
This study is currently recruiting participants.
Study NCT00031681
Information provided by National Cancer Institute (NCI)
First Received: March 8, 2002
Last Updated: August 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
